Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting? by Cinzia Solinas, Debora Fumagalli, Maria Vittoria Dieci

Get full text

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives by Rafael Caparica, Matteo Lambertini, Noam Pondé, Debora Fumagalli, Evandro de Azambuja, Martine Piccart

Get full text

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays. by Vinu Jose, Debora Fumagalli, Françoise Rothé, Samira Majjaj, Sherene Loi, Stefan Michiels, Christos Sotiriou

Get full text

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome by Debora Fumagalli, David Gacquer, Françoise Rothé, Anne Lefort, Frederick Libert, David Brown, Naima Kheddoumi, Adam Shlien, Tomasz Konopka, Roberto Salgado, Denis Larsimont, Kornelia Polyak, Karen Willard-Gallo, Christine Desmedt, Martine Piccart, Marc Abramowicz, Peter J. Campbell, Christos Sotiriou, Vincent Detours

Get full text

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group by Marion Maetens, David Brown, Alexandre Irrthum, Philippe Aftimos, Giuseppe Viale, Sibylle Loibl, Jean-François Laes, Peter J. Campbell, Alastair Thompson, Javier Cortes, Sabine Seiler, Sara Vinnicombe, Mafalda Oliveira, Françoise Rothé, Yacine Bareche, Debora Fumagalli, Dimitrios Zardavas, Christine Desmedt, Martine Piccart, Sherene Loi, Christos Sotiriou

Get full text